These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 19396896)
1. Searching for disease modifiers-PKC activation and HDAC inhibition - a dual drug approach to Alzheimer's disease that decreases Abeta production while blocking oxidative stress. Kozikowski AP; Chen Y; Subhasish T; Lewin NE; Blumberg PM; Zhong Z; D'Annibale MA; Wang WL; Shen Y; Langley B ChemMedChem; 2009 Jul; 4(7):1095-105. PubMed ID: 19396896 [TBL] [Abstract][Full Text] [Related]
2. New amide-bearing benzolactam-based protein kinase C modulators induce enhanced secretion of the amyloid precursor protein metabolite sAPPalpha. Kozikowski AP; Nowak I; Petukhov PA; Etcheberrigaray R; Mohamed A; Tan M; Lewin N; Hennings H; Pearce LL; Blumberg PM J Med Chem; 2003 Jan; 46(3):364-73. PubMed ID: 12540236 [TBL] [Abstract][Full Text] [Related]
3. Bryostatin-1 vs. TPPB: dose-dependent APP processing and PKC-α, -δ, and -ε isoform activation in SH-SY5Y neuronal cells. Yi P; Schrott L; Castor TP; Alexander JS J Mol Neurosci; 2012 Sep; 48(1):234-44. PubMed ID: 22700373 [TBL] [Abstract][Full Text] [Related]
4. Etazolate, a neuroprotective drug linking GABA(A) receptor pharmacology to amyloid precursor protein processing. Marcade M; Bourdin J; Loiseau N; Peillon H; Rayer A; Drouin D; Schweighoffer F; Désiré L J Neurochem; 2008 Jul; 106(1):392-404. PubMed ID: 18397369 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and pharmacological evaluation of 8- and 9-substituted benzolactam-v8 derivatives as potent ligands for protein kinase C, a therapeutic target for Alzheimer's disease. Mach UR; Lewin NE; Blumberg PM; Kozikowski AP ChemMedChem; 2006 Mar; 1(3):307-14. PubMed ID: 16892365 [TBL] [Abstract][Full Text] [Related]
6. A cellular model of Alzheimer's disease therapeutic efficacy: PKC activation reverses Abeta-induced biomarker abnormality on cultured fibroblasts. Khan TK; Nelson TJ; Verma VA; Wender PA; Alkon DL Neurobiol Dis; 2009 May; 34(2):332-9. PubMed ID: 19233276 [TBL] [Abstract][Full Text] [Related]
7. New protein kinase C activator regulates amyloid precursor protein processing in vitro by increasing alpha-secretase activity. Yang HQ; Pan J; Ba MW; Sun ZK; Ma GZ; Lu GQ; Xiao Q; Chen SD Eur J Neurosci; 2007 Jul; 26(2):381-91. PubMed ID: 17650113 [TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effects of bergenin in Alzheimer's disease: Investigation through molecular docking, in vitro and in vivo studies. Barai P; Raval N; Acharya S; Borisa A; Bhatt H; Acharya N Behav Brain Res; 2019 Jan; 356():18-40. PubMed ID: 30118774 [TBL] [Abstract][Full Text] [Related]
9. Huperzine A regulates amyloid precursor protein processing via protein kinase C and mitogen-activated protein kinase pathways in neuroblastoma SK-N-SH cells over-expressing wild type human amyloid precursor protein 695. Peng Y; Lee DY; Jiang L; Ma Z; Schachter SC; Lemere CA Neuroscience; 2007 Dec; 150(2):386-95. PubMed ID: 17945434 [TBL] [Abstract][Full Text] [Related]
10. Role of the APP non-amyloidogenic signaling pathway and targeting alpha-secretase as an alternative drug target for treatment of Alzheimer's disease. Bandyopadhyay S; Goldstein LE; Lahiri DK; Rogers JT Curr Med Chem; 2007; 14(27):2848-64. PubMed ID: 18045131 [TBL] [Abstract][Full Text] [Related]
13. Promising multifunctional anti-Alzheimer's dimer bis(7)-Cognitin acting as an activator of protein kinase C regulates activities of alpha-secretase and BACE-1 concurrently. Fu H; Dou J; Li W; Cui W; Mak S; Hu Q; Luo J; Lam CS; Pang Y; Youdim MB; Han Y Eur J Pharmacol; 2009 Nov; 623(1-3):14-21. PubMed ID: 19765582 [TBL] [Abstract][Full Text] [Related]
14. Neuroprotection and neurorescue against Abeta toxicity and PKC-dependent release of nonamyloidogenic soluble precursor protein by green tea polyphenol (-)-epigallocatechin-3-gallate. Levites Y; Amit T; Mandel S; Youdim MB FASEB J; 2003 May; 17(8):952-4. PubMed ID: 12670874 [TBL] [Abstract][Full Text] [Related]
15. Attenuation of amyloid-β generation by atypical protein kinase C-mediated phosphorylation of engulfment adaptor PTB domain containing 1 threonine 35. Chau DD; Yung KW; Chan WW; An Y; Hao Y; Chan HE; Ngo JC; Lau KF FASEB J; 2019 Nov; 33(11):12019-12035. PubMed ID: 31373844 [TBL] [Abstract][Full Text] [Related]
16. Effect of trichostatin A on gelsolin levels, proteolysis of amyloid precursor protein, and amyloid beta-protein load in the brain of transgenic mouse model of Alzheimer's disease. Yang W; Chauhan A; Wegiel J; Kuchna I; Gu F; Chauhan V Curr Alzheimer Res; 2014; 11(10):1002-11. PubMed ID: 25387339 [TBL] [Abstract][Full Text] [Related]
17. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease. Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867 [TBL] [Abstract][Full Text] [Related]
18. Dexmedetomidine attenuates the toxicity of β‑amyloid on neurons and astrocytes by increasing BDNF production under the regulation of HDAC2 and HDAC5. Wang Y; Jia A; Ma W Mol Med Rep; 2019 Jan; 19(1):533-540. PubMed ID: 30483749 [TBL] [Abstract][Full Text] [Related]
19. Cryptotanshinone, a compound from Salvia miltiorrhiza modulates amyloid precursor protein metabolism and attenuates beta-amyloid deposition through upregulating alpha-secretase in vivo and in vitro. Mei Z; Zhang F; Tao L; Zheng W; Cao Y; Wang Z; Tang S; Le K; Chen S; Pi R; Liu P Neurosci Lett; 2009 Mar; 452(2):90-5. PubMed ID: 19154776 [TBL] [Abstract][Full Text] [Related]
20. L-3-n-butylphthalide improves cognitive impairment and reduces amyloid-beta in a transgenic model of Alzheimer's disease. Peng Y; Sun J; Hon S; Nylander AN; Xia W; Feng Y; Wang X; Lemere CA J Neurosci; 2010 Jun; 30(24):8180-9. PubMed ID: 20554868 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]